GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

GLP-1 S (5 mg) / SLU-PP-332 (1 mg) × 30 Tablets

This dual-compound research formulation combines GLP-1 S and SLU-PP-332 — two molecules studied for their complementary effects on metabolic regulation, energy expenditure, and glucose signaling. Designed for investigators exploring pathways that integrate AMPK activation with GLP-1 receptor modulation, this blend supports preclinical research into energy balance, metabolic enhancement, and cellular signaling synergy.

Blend Composition (Per Tablet):
GLP-1 S – 5 mg
SLU-PP-332 – 1 mg
30 tablets per bottle

Key Characteristics:

• GLP-1 S: Synthetic peptide analogue investigated for its influence on GLP-1 receptor signaling, appetite regulation, and glucose metabolism

• SLU-PP-332: AMPK pathway modulator studied for its role in mitochondrial activity, endurance, and metabolic regulation

• Dual-mechanism formulation designed to explore synergistic metabolic pathways

• Oral tablet format providing stable, controlled compound delivery for experimental reproducibility

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.